Related Experiment Video
Updated: Aug 15, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Locoregional Recurrence After Mastectomy: Risk Factors and Implications for Postmastectomy Radiation
Lucie T Lefbom1, Caleigh Smith2, Chengli Shen3
1University of Virginia School of Medicine, Charlottesville, Virginia.
The Journal of Surgical Research
|August 13, 2026
Summary
Locoregional recurrence (LRR) after mastectomy is low. Lymphovascular invasion and close margins are key predictors of LRR, not nodal status, guiding personalized postmastectomy radiation therapy (PMRT) decisions.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- Locoregional recurrence (LRR) is a significant concern following mastectomy for breast cancer.
- Contemporary recurrence patterns are not well-defined given modern therapies and increased use of postmastectomy radiation therapy (PMRT).
Purpose of the Study:
- To define contemporary recurrence patterns after mastectomy.
- To identify predictors of LRR and overall recurrence in the era of modern breast cancer treatment.
Main Methods:
- Retrospective review of 595 women undergoing mastectomy (2014-2020).
- Analysis of patient demographics, clinicopathologic features, treatments, and outcomes.
- Use of Cox proportional hazards regression to identify LRR predictors.
Main Results:
- The 5-year LRR rate was 3.9% (median follow-up 4.8 years).
- Lymphovascular invasion (HR 6.28) and close margins (HR 3.02) were independent predictors of LRR.
- Nodal status and young age did not predict LRR; higher stage, close/positive margins, and lymphovascular invasion predicted overall recurrence.
Conclusions:
- LRR rates remain low in contemporary breast cancer patients post-mastectomy.
- Lymphovascular invasion and close surgical margins are significant independent predictors of LRR.
- Findings support focusing on margin status and lymphovascular invasion for personalized PMRT recommendations.